Page 18 - Read Online
P. 18

Fowler et al. Hepatoma Res 2020;6:19  I  http://dx.doi.org/10.20517/2394-5079.2020.21                                             Page 3 of 10


















               Figure 1. Gadoxetate enhanced MRI: 55 year-old male with chronic hepatitis B infection. A targetoid observation (65 mm) exhibits
               features of LR-M: rim arterial phase hyperenhancement and peripheral washout (arrowheads). After biopsy, the lesion was diagnosed as
               liver metastasis from colorectal cancer



















               Figure 2. Gadoxetate enhanced MRI: 65 year-old male with chronic hepatitis C cirrhosis. A 60-mm observation exhibits features of LR-5:
               non rim arterial phase hyperenhancement (arrows), washout and capsule (arrowheads) indicating definite hepatocellular carcinoma.
               Ancillary features seen are a mosaic architecture and hepatobiliary phase hypointensity

               (LR-M). This task will be expanded on below. Once TIV, benign entities, and other malignancies have been
               excluded in a step-wise fashion, the radiologist should be left with solid hepatocellular nodules that are
               further classified as intermediate (LR-3), probable (LR-4) or definite HCC (LR-5), according to the presence
               and number of major features. In LI-RADS, the major features include size, APHE, washout appearance,
               delayed enhancing capsule, and threshold growth.

               The LR-M category is a very important step in the algorithm, as non-HCC malignancies must be considered
               to avoid false positives in diagnosing LR-5. The features of LI-RADS LR-M primarily reflect the features
               of iCCA as described above: targetoid patterns in dynamic enhancement, diffusion weighted imaging, and
                                            [15]
               hepatobiliary phase appearances . Figure 1 demonstrates a typical non-HCC malignancy with LR-M
               targetoid features. For comparison, Figure 2 shows a typical LR-5, definite HCC, on MRI. The presence of
               any targetoid feature is sufficient for LR-M categorization, even if the observation has some features of HCC.
               Additional features may be applied in malignant observations that do not meet LR-5 or TIV criteria: marked
               diffusion restriction, necrosis, and infiltrative appearances. Beyond the LR-M features described here,
               there are ancillary features that favor malignancy in general (e.g., subthreshold growth, corona appearance,
               hepatobiliary phase hypointensity); however, these ancillary features are not, by themselves, sufficient to
               categorize an observation as LR-M.

               LI-RADS recognizes that imaging features and morphologies are subjective in nature. To help radiologists,
               there are tie breaking rules both for features and final diagnostic categories. When in doubt, the radiologist
               should refer to the category or feature that is less specific for HCC. For example, if there is a question
               of whether APHE is rim or nonrim, the radiologist should assign rim APHE. Likewise, if there is doubt
               between LR-5 vs. LR-M, the radiologist should assign LR-M.
   13   14   15   16   17   18   19   20   21   22   23